Korean J Parasitol.  2011 Jun;49(2):153-159. 10.3347/kjp.2011.49.2.153.

Assessment of Loiasis and Outcomes of Ivermectin Masstreatment in Ijebu-North, Nigeria

Affiliations
  • 1Department of Zoology, University of Ibadan, Nigeria. ess_hassan@yahoo.com
  • 2Department of Zoology, University of Lagos, Nigeria.
  • 3Department of Plant Science and Applied Zoology, Olabisi Onabanjo University, Nigeria.

Abstract

A total of 286 individuals from 3 selected communities (Areedi-Aje, Ipakodo/Ojokodo, and Ijebu-Igbo) of Ijebu-North, southwestern Nigeria were examined for Loa loa microfilaremia using finger prick blood smear, between December 2008 and March 2009. Rapid assessment procedure for loiasis (RAPLOA) was used to obtain information, from 187 Ijebu-Igbo residents, on adverse reactions experienced from retrospective treatments with ivermectin and history of eye worm. Only 33.9% of the respondents reported having had a history of eye worm while 33.2% had microfilaremia. The demographic factor of gender was not significant determinants of the prevalence (P>0.05) while age was significant (P<0.05). The highest prevalence of eye worm history and microfilaremia were recorded in 61-70 and 15-20 years of age categories, respectively. Ijebu-Igbo had 27.3% eye worm history, 32.1% microfilaremia, and the highest intensity of 140 microfilariae (mf)/ml. Ipakodo area had the highest eye worm history of 54.4% and the highest intensity of 420 mf/ml. Areedi-Aje had the highest occurrence of 45.2% microfilaremia and the highest intensity of 460 mf/ml. Predictably, Areedi-Aje and Ipakodo areas were high risk communities. The low intensity of L. loa infection with an insignificant (2.1%; P>0.05) adverse reactions from 187 subjects involved in the retrospective ivermectin administration confirmed that ivermectin delivery may be considered safe. The community-directed treatment with ivermectin (CDTI) programme was most probably responsible for the low prevalence and intensity.

Keyword

Loa loa; microfilaremia; ivermectin; adverse reaction; Nigeria

MeSH Terms

Adolescent
Adult
Age Factors
Aged
Animals
Female
Filaricides/*administration & dosage/adverse effects
Geography
Humans
Ivermectin/*administration & dosage/adverse effects
Loa/drug effects/*isolation & purification
Loiasis/*drug therapy/*epidemiology
Male
Middle Aged
Nigeria/epidemiology
Prevalence
Treatment Outcome
Young Adult
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr